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The Kruskal-Wallis test is a popular non-parametric statistical test for identifying expression quan-
titative trait loci (eQTLs) from genome-wide data due to its robustness against variations in the under-
lying genetic model and expression trait distribution, but testing billions of marker-trait combinations
one-by-one can become computationally prohibitive. We developed kruX, an algorithm implemented
in Matlab, Python and R that uses matrix multiplications to simultaneously calculate the Kruskal-
Wallis test statistic for several millions of marker-trait combinations at once. KruX is more than ten
thousand times faster than computing associations one-by-one on a typical human dataset. We used
kruX and a dataset of more than 500k SNPs and 20k expression traits measured in 102 human blood
samples to compare eQTLs detected by the Kruskal-Wallis test to eQTLs detected by the parametric
ANOVA and linear model methods. We found that the Kruskal-Wallis test is more robust against data
outliers and heterogeneous genotype group sizes and detects a higher proportion of non-linear asso-
ciations, but is more conservative for calling additive linear associations. In summary, kruX enables
the use of robust non-parametric methods for massive eQTL mapping without the need for a high-
performance computing infrastructure and is freely available from http://krux.googlecode.com.
I. BACKGROUND
Genome-wide association studies have identified
hundreds of DNA variants associated to complex traits
including disease in human alone [1]. To understand
how these variants affect disease risk, genotype and or-
ganismal phenotype data are integrated with interme-
diate molecular phenotypes to reconstruct disease net-
works [2]. A first step in this procedure is to iden-
tify DNA variants that underpin variations in expres-
sion levels (eQTLs) of transcripts [3], proteins [4] or
metabolites [5]. As modern technologies routinely pro-
duce genotype and expression data for a million or
more single-nucleotide polymorphisms (SNPs) and ten-
thousands of molecular abundance traits in a single ex-
periment, often repeated across multiple cell or tissue
types, the number of statistical tests to be performed
when testing each SNP for association to each trait is
huge. Furthermore, multiple testing correction requires
all tests to be repeated several times on permuted data
to generate an empirical null distribution. Despite being
trivially parallelisable, the computational burden of test-
ing SNP-trait associations one-by-one quickly becomes
prohibitive.
Recently a new approach (“matrix-eQTL”) was devel-
oped which uses the fact that the test statistics for the
additive linear regression and ANOVA models can be
expressed as multiplications between rescaled genotype
and expression data matrices, thereby realising a dra-
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matic speed-up compared to traditional QTL-mapping
algorithms [6]. A limitation of these models is their as-
sumption that the expression data is always normally
distributed within each genotype group. For this rea-
son, QTL and eQTL studies have frequently used non-
parametric methods which are more robust against vari-
ations in the underlying genetic model and trait distri-
bution [7, 8]. In particular, the non-parametric Kruskal-
Wallis one-way analysis of variance [9] does not assume
normal distributions and reports small P-values if the
median of at least one genotype group is significantly
different from the others [8].
Here we report a matrix-based algorithm (“kruX”),
implemented in Matlab, Python and R, to simultane-
ously calculate the Kruskal-Wallis test statistics for sev-
eral millions of SNP-trait pairs at once that is more than
ten thousand times faster than calculating them one-by-
one on a human test dataset with more than 500,000
SNPs and 20,000 expression traits. Additional benefits
of kruX include the explicit handling of missing values
in both genotype and expression data and the support
of genetic markers with any number of alleles, includ-
ing variable allele numbers within a single dataset.
II. IMPLEMENTATION
A. Input data
KruX takes as input genotype values of M genetic
markers and expression levels of N transcripts, proteins
or metabolites in K individuals, organised in an M× K
genotype matrix G and N × K expression data matrix
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2D. Genetic markers take values 0, 1, . . . , `, where ` is the
maximum number of alleles (` = 2 for biallelic mark-
ers), while molecular traits take continuous values. We
use built-in functions of Matlab, Python and R to con-
vert the expression data matrix D to a matrix R of data
ranks, ranked independently over each row (i.e. molec-
ular trait). KruX assumes that the input expression data
has been adjusted for covariates if it is necessary to do so
[10, 11] and all data quality control has been performed.
B. Calculation of the Kruskal-Wallis test statistic by
matrix multiplication
The genotype matrixG is first converted to sparse log-
ical index matrices Ii of the same size, where Ii(m, k) = 1
if G(m, k) = i and 0 otherwise (i = 0, . . . , `). Next ob-
serve that the 1 × M vector Ni with entries Ni(m) =
∑Kk=1 Ii(m, k) and N ×M matrices Si with entries
Si(n,m) =
K
∑
k=1
R(n, k) Ii(m, k) =
(
R · ITi
)
(n,m), (1)
are respectively the number of individuals and the sum
of ranks for the nth trait in the ith genotype group of the
mth marker. We can then calculate an N × M matrix S
with entries
S(n,m) =
12
K(K+ 1)
`
∑
i=0
Si(n,m)2
Ni(m)
− 3(K+ 1), (2)
using efficient vectorised operations. If none of the rows
in D contain ties, then each entry S(n,m) equals the
Kruskal-Wallis test statistic for testing trait n against
marker m [9]. For markers with less than the maxi-
mum of ` genotype values, 0/0 division will result in
NaN columns in the intermediate matrices with entries
Si(n,m)2/Ni(m) for the empty genotype groups. By re-
placing all NaN’s by zeros before making the sum in
eq. (2), the corresponding entries in S will be the cor-
rect statistics for a test with fewer than ` degrees of free-
dom. Thus we need `+ 1 matrix multiplications and the
associated element-wise operations to calculate the test
statistic values for all marker-trait combinations.
C. P-value calculation and empirical FDR correction
KruX takes as input a P-value threshold Pc, calculates
the corresponding test statistic thresholds for d degrees
of freedom (d = 1, . . . , `− 1), and identifies the entries
in S which exceed the appropriate threshold value. For
these entries only a P-value is calculated using the χ2
distribution. Empirical false-discovery rate (FDR) val-
ues are computed by repeating the P-value calculation
(with the same Pc) multiple times on data where the
columns of the expression data ranks are randomly per-
muted. The FDR value for any value P ≤ Pc is defined
as the ratio of the average number of associations with
P′ ≤ P in the randomised data to the number of associ-
ations with P′ ≤ P in the real data.
D. Handling missing values
When data values are missing for some marker or
trait, all test statistics for that marker or trait need to
be adjusted for a smaller number of observations. For
the expression data, missing values are easily handled
since the ranking algorithms will give NaN’s the high-
est rank. By setting the entries corresponding to missing
values in D to zero in R, eq. (1) still produces the correct
sums of ranks, while the matrix multiplication
(
Z · ITi
)
(n,m) =
K
∑
k=1
Z(n, k) Ii(m, k) = Ni(n,m),
where Z is the N × K matrix with Z(n, k) = 0 when-
ever D(n, k) = NaN and 1 otherwise, produces the cor-
rected number of individuals in the ith group of the mth
marker for the nth trait. Replacing the constant K in eq.
(2) by a N × M matrix K where K(n,m) is the num-
ber of non-missing samples for trait n and performing
element-wise division and substraction operations then
gives the correct test statistic for all pairs.
Handling missing genotype data is less easy because
the expression ranks that need to be adjusted are specific
to each marker-trait combination (e.g if a marker has a
missing value where a trait has rank r1, then all sam-
ples with ranks r = r1 + 1, . . . ,K need to be lowered by
1). KruX uses the fact that missing genotype values are
generally due to sample quality and therefore patterns
of missing values are often repeated among markers.
For each unique missing value pattern, a new genotype
matrix for all markers with that pattern and a new ex-
pression data matrix with the corresponding samples re-
moved are constructed to calculate the test statistics for
all affected marker gene combinations. Missing geno-
type data increases the computational cost of the algo-
rithm considerably and it is recommended to limit the
number of missing values by only considering markers
with a sufficiently high call rate.
E. Handling tied data
In the presence of tied observations, the statistic in eq.
(2) needs to be divided by a factor 1− ∑ TK3−K , where the
summation is over all groups of ties and T = t3 − t for
each group of ties, with t the number of tied data in the
group [9]. The factor T is automatically computed for
each trait during the ranking step and the matrix S is
therefore easily corrected using element-wise matrix op-
erations (Matlab version only). Whereas ties are usually
rare in standard gene expression datasets, the ability to
3handle tied data expands the scope of kruX to count-
based, discretised or qualitative data types.
F. Data slicing
Since kruX needs to create intermediate matrices of
size N × M, where N is the number of traits and M
the number of markers, which do not usually fit into
memory for large datasets, kruX supports the use of
data ‘slices’ to divide the complete data into manageable
chunks. In typical applications, the number of markers
is one or two orders of magnitude larger than the num-
ber of traits. Therefore the default behaviour of kruX is
to keep the expression data as a single matrix and simul-
taneously test all traits against subsets of markers. The
user can provide either a slice size and kruX will process
marker blocks of this size serially, or a slice size and ini-
tial marker and kruX will process a single slice starting
from that marker. The latter option allows trivial paral-
lelisation across multiple processors.
III. RESULTS AND DISCUSSION
A. Validation data
To test kruX we provide example analysis scripts and
a small anonymised dataset of 2,000 randomly selected
genes and markers from 100 randomly selected yeast
segregants [12]. Here we describe an application of kruX
on a human dataset of 19,610 genes and 530,222 SNP
markers measured in 102 whole blood samples from the
Stockholm Atherosclerosis Gene Expression (STAGE)
study [13]. All SNPs in the dataset had minor allele fre-
quency greater than 5%, no missing values and proba-
bility to be in Hardy-Weinberg equilibrium greater than
10−6.
B. kruX is exact and fast
We first confirmed that kruX produces the same re-
sults as testing marker-trait combinations one-by-one
using the built-in Kruskal-Wallis functions to verify the
correctness of our implementations. To test the per-
formance of kruX we divided the genotype data into
slices of variable size and extrapolated the total run
time from running a single genotype data slice against
all expression traits and multiplying by the number of
slices needed to cover the entire set of 530,222 SNPs.
The total run time rapidly decreases until a genotype
slice contains about 1,000 SNPs and stays almost con-
stant thereafter. On a laptop with 8 GB RAM, the limit
is reached at around 3,000 SNPs per slice after which
run time sharply increases again due to memory limita-
tions (Fig. 1). We therefore recommend a genotype slice
size of around 2,000 markers, resulting for this dataset in
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FIG. 1. kruX runtime on STAGE data. Total extrapolated
single-CPU run time in seconds for the Matlab implementa-
tion of kruX for different numbers of SNP markers per data
slice (see main text for details). Green squares are times on a
high-memory server with 256 GB RAM and 2.20 GHz proces-
sor and red circles are times on a laptop with 8 GB RAM and
2.70 GHz processor. The insert shows the continuation of the
green squares upto a slice size of 10,000 markers.
around 250 separate jobs, which will take around 2,500
seconds (42 minutes) when run serially on a single pro-
cessor. By comparison, the total extrapolated run time
when computing all 19,610 × 530,222 associations one-
by-one using the built-in Kruskal-Wallis function on the
same hardware as in Fig. 1 are respectively 4.8 · 107 (256
GB, 2.20 GHz server) and 2.6 · 107 (8 GB, 2.70 GHz lap-
top) seconds such that kruX is respectively 17,000 and
11,000 times faster on this particular dataset. On the
same dataset and hardware, the comparatively simpler
matrix operations for the parametric tests in matrix-
eQTL took respectively 5 minutes (linear model) and 7.4
minutes (ANOVA model).
C. The Kruskal-Wallis test is more conservative than
corresponding parametric tests
Next we compared the output of kruX and matrix-
eQTL’s parametric ANOVA and linear model (hence-
forth called “ANOVA” and “linear”) methods. The
Kruskal-Wallis test is more conservative than the
ANOVA and linear methods, i.e. it has a higher nom-
inal P-value for almost all marker-trait combinations
(Fig. 2). Since random data will be subjected to the same
biases, nominal P-values cannot be directly compared
to assess significance. We therefore performed empiri-
cal FDR correction for multiple testing using three ran-
domised datasets (cf. Implementation). Surprisingly,
after FDR correction only a limited number of associa-
tions remained for ANOVA even at an FDR threshold
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FIG. 2. Comparison of kruX vs. parametric ANOVA and lin-
ear models. Comparison of nominal non-parametric P-values
calculated by kruX vs. parametric ANOVA (a) and linear mod-
els (b), showing all cis-acting eQTL-gene pairs with P < 10−3
detected by both methods (blue dots) and by only one of the
methods (red crosses). The black line indicates the line with
slope y = x.
(a) overlap kruX vs. ANOVA vs. linear model (all eQTL) (b) overlap kruX vs. ANOVA vs. linear model (cis-eQTL)
FIG. 3. Comparison of kruX vs. parametric ANOVA and lin-
ear models. Comparison of all eQTL-gene pairs (FDR=30%)
(a) and all cis-acting eQTL-gene pairs (FDR=10%) (b) after em-
pirical FDR correction between kruX (blue lower left set), para-
metric ANOVA (yellow upper set), and linear models (red
lower right set).
of 30%, whereas the number of associations detected by
kruX and the linear method was comparable (Fig. 3(a)).
Detailed analysis showed that this is due to pairing of
SNPs with rare homozygous minor alleles (one or two
samples) to genes with outlier expression levels, result-
ing in extremely low P-values for the ANOVA method
in real as well as randomised data (see also below). To
reduce the incidence of chance associations between sin-
gleton genotype groups and outlying expression val-
ues in the ANOVA method we repeated the empiri-
cal FDR correction, this time keeping only marker-trait
combinations within 1Mbp of each other (“cis-eQTLs”).
At an FDR threshold of 10% the number of significant
cis-eQTL-gene pairs is indeed comparable between the
three methods, with a large proportion of pairs detected
by all three of them (Fig. 3(b)).
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FIG. 4. Relative proportions of eQTL types. Relative pro-
portion of eQTL-types for cis-eQTLs common to all 3 methods
and specific to each method; white (bottom), skewed geno-
type group sizes; yellow (middle), non-linear eQTLs; red (top),
others. The absolute number of eQTLs in each group is 7,193
(Common), 1,663 (kruX), 701 (ANOVA) and 5,102 (Linear), cf.
Fig. 3(b).
D. The Kruskal-Wallis test is more robust and detects
more non-linear associations
We classified eQTL-gene pairs as “skewed group
sizes” (smallest genotype group less than 5 elements),
non-skewed “non-linear” [median of heterozygous and
homozygous samples significantly different (Wilcoxon
rank sum P < 0.05)] and non-skewed “other” (all
others). Cis-associations identified exclusively by the
Kruskal-Wallis test are more often non-linear and the
overall distribution of eQTL-types is more similar to as-
sociations identified by all three methods, compared to
the ANOVA and linear methods (Fig. 4 and Fig. 5(a-
b)). Of the 701 associations exclusively identified us-
ing the parametric ANOVA method, 657 (94%) had
skewed group sizes, including 426 (61%) with a single-
ton genotype group (the aforementioned ‘outliers’, cf.
Fig. 5(c)). The associations exclusively identified by the
linear method also contained a much higher proportion
of SNPs with skewed group sizes than the correspond-
ing kruX associations (36% vs. 23%) and, as expected,
a reduced number of non-linear associations (Fig. 4 and
Fig. 5(d)).
IV. CONCLUSIONS
We have developed kruX, a software tool that uses
matrix multiplications to simultaneously calculate the
Kruskal-Wallis test statistics for millions of marker-trait
combinations in a single operation, thereby realising
a dramatic speed-up compared to calculating the test
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FIG. 5. Representative examples of eQTL associations. (a-
b) Non-linear associations. kruX identifies more non-linear
relations where the gene expression level of the heterozygous
samples lies outside the typical range of the homozygous sam-
ples (a) or where one allele has a dominant effect on the gene
expression level (b). (c-d) Problematic associations. Paramet-
ric ANOVA gives high significance to spurious associations for
genes with outlying expression samples that coincide with sin-
gleton genotype groups (c). Associations with skewed geno-
type group sizes where the model assumptions are difficult to
ascertain achieve high significance using linear models (d).
statistics one-by-one. The availability of a fast method
to identify eQTL associations using a non-parametric
test allowed us to assess in more detail how differences
in model assumptions compared to parametric methods
lead to differences in identified eQTLs. Our results on
a typical human dataset indicate that the the parametric
ANOVA method is highly sensitive to the presence of
outlying gene expression values and SNPs with single-
ton genotype groups. We caution against its use without
prior filtering of such outliers. Linear models reported
the highest number of eQTL associations after empiri-
cal FDR correction. These are understandably biased to-
wards additive linear associations and were also sensi-
tive to the presence of skewed genotype group sizes, al-
beit to a much lesser extent than the parametric ANOVA
method. The Kruskal-Wallis test on the other hand is
robust against data outliers and heterogeneous geno-
type group sizes and detects a higher proportion of non-
linear associations, but it is more conservative for calling
additive linear associations than linear models, even af-
ter FDR correction.
In summary, kruX enables the use of non-parametric
methods for massive eQTL mapping without the need
for a high-performance computing infrastructure.
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